Agility Robotics, Inc. officer Anastasia Lang filed a statement of changes in beneficial ownership on November 6, 2026, disclosing a stock option award of 2,760,599 shares received in connection with the company's business combination with Churchill Capital Corp XI.
Director Damion Shelton filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 9,938,151 shares of common stock and 230,050 stock options in Agility Robotics, Inc. (NASDAQ:AGLT) on November 4, 2026, as a result of the company's business combination …
Jonathan Hurst, Chief Robot Officer of Agility Robotics, Inc., filed a Form 4 on November 6, 2026, disclosing the acquisition of 12,422,709 shares of common stock and 230,050 stock options on November 4, 2026, as a result of the company's business combination with Churchill …
Agility Robotics, Inc. CEO and Director Margaret L. Johnson filed a Form 4 on November 6, 2026, disclosing the acquisition of 347,790 shares of Common Stock and 5,061,099 stock options on November 4, 2026, as a result of the company's business combination with the …
Kenneth G. Romanzi, Chief Executive Officer and Director of Natures Sunshine Products Inc, filed a Form 4 on November 6, 2026, disclosing a disposition of 15,021 common shares on November 4, 2026, to cover taxes upon the vesting of restricted stock units.
Apollo Global Management Chief Legal Officer Whitney Chatterjee filed a Form 4 on November 6, 2026, disclosing two sales of Apollo Global Management, Inc. common stock executed on November 4, 2026.
Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp (NASDAQ:ADPT), filed a Form 4 on November 6, 2026, disclosing option exercises and open-market share sales across three trading days from November 4 through November 6, 2026, all executed under a Rule 10b5-1 trading plan.
Morgan Stanley and its subsidiary Morgan Stanley Canada Limited filed an amended beneficial ownership statement on November 6, 2026, disclosing that both entities had fallen below five percent ownership of MDA Space Ltd. common shares as of October 31, 2026.
Nathan G. Brower, EVP and General Counsel of Natures Sunshine Products Inc (NASDAQ:NATR), filed a Form 4 on November 6, 2026, disclosing RSU vesting transactions and related tax-withholding disposals that occurred on November 4, 2026.
Jonathan David Lanoy, SVP and Chief Accounting Officer of Natures Sunshine Products Inc, filed a Form 4 on November 6, 2026, disclosing RSU vestings and related tax-withholding disposals of common shares on November 4, 2026.